Table 2.
Clinical characteristics of listed patients according to the mortality status
| Characteristics | Died/Delisted (n = 101) | All others (n = 252) | P value |
|---|---|---|---|
| Age (years) | 57 ± 9 | 55 ± 9 | 0.18 |
| Albumin (g/dL, 3.5–5.5) | 3 ± 3 | 3 ± 1 | 0.53 |
| Sodium (mmol/L, 133–146) | 134 ± 5 | 135 ± 6 | 0.30 |
| MELD score | 17 ± 8 | 16 ± 9 | 0.38 |
| Hepatic encephalopathy | 0.74 | ||
| None | 48 (50) | 107 (47) | |
| Well controlled | 43 (45) | 111 (49) | |
| Poorly controlled | 5 (5) | 9 (4) | |
| Ascites | 0.69 | ||
| None | 35 (36) | 94 (42) | |
| Mild | 41 (43) | 87 (38) | |
| Refractory | 20 (21) | 46 (20) | |
| HCC | 50 (50) | 91 (36) | 0.02 |
| Body composition characteristics | |||
| BMI (kg/m2) | 27 ± 6 | 28 ± 5 | 0.07 |
| PMI (cm2/m2) | 5.5 ± 1.7 | 6.2 ± 1.6 | <0.001 |
| SMI (cm2/m2) | 44 ± 9 | 49 ± 9 | <0.001 |
| Males | |||
| PMI (cm2/m2) | 6.2 ± 1.6 | 6.6 ± 1.6 | 0.12 |
| SMI (cm2/m2) | 47 ± 7 | 51 ± 9 | 0.003 |
| Females | |||
| PMI (cm2/m2) | 4.4 ± 1.3 | 5.2 ± 1.1 | 0.001 |
| SMI (cm2/m2) | 39 ± 9 | 43 ± 7 | 0.009 |
Numbers in parentheses are percentages.
BMI, body mass index; HCC, hepatocellular carcinoma; MELD, Model for End‐stage Liver Disease; PMI, psoas muscle index; SMI, skeletal muscle index.